September 30, 2003
Multiple Sclerosis Trust
Preliminary results from a study of the psychological effects of cannabis were presented this week at the ECTRIMS (European Committee for Treatment and Research in MS) meeting in Milan. The research is being funded by the MS Trust.
The study is following 109 people taking part in the larger Cannabis and MS study. The preliminary results showed the cognitive scores of all the participants at the start and end of the study remained within the expected range for people with MS. Researchers have concluded that no significant effect on cognition was shown in people using medicinal cannabis.
The longer-term psychological effects of cannabis are still being investigated
by the three-year study, which is due to conclude in February 2004.
Copyright © 2003, Multiple Sclerosis Trust